Multiple sclerosis management during the COVID-19 pandemic

BACKGROUND: People with multiple sclerosis (MS) may be at higher risk for complications from the 2019 coronavirus (COVID-19) pandemic due to use of immunomodulatory disease modifying therapies (DMTs) and greater need for medical services. OBJECTIVES: To evaluate risk factors for COVID-19 susceptibil...

Descripción completa

Detalles Bibliográficos
Autores principales: Moss, Brandon P, Mahajan, Kedar R, Bermel, Robert A, Hellisz, Kelsey, Hua, Le H, Hudec, Timothy, Husak, Scott, McGinley, Marisa P, Ontaneda, Daniel, Wang, Zhini, Weber, Malory, Tagliani, Paula, Cárdenas-Robledo, Simón, Zabalza, Ana, Arrambide, Georgina, Carbonell-Mirabent, Pere, Rodríguez-Barranco, Marta, Sastre-Garriga, Jaume, Tintore, Mar, Montalban, Xavier, Douglas, Morgan, Ogbuokiri, Esther, Aravidis, Berna, Cohen, Jeffrey A, Mowry, Ellen M, Fitzgerald, Kathryn C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424611/
https://www.ncbi.nlm.nih.gov/pubmed/32772807
http://dx.doi.org/10.1177/1352458520948231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424611/
https://www.ncbi.nlm.nih.gov/pubmed/32772807
http://dx.doi.org/10.1177/1352458520948231

Ejemplares similares